Moderna NASDAQ MRNA
$132.06 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Показатель: 35 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

56.92B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

50.28B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.49
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

431.00M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-48.00 %
Upcoming events Moderna All events
No upcoming events scheduled

Stock chart Moderna

Stock analysis Moderna

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
3.89 17.10
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
4.02 4.42
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
3.04 10.96
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.40 -0.0200
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
85.73 22.67

Price change Moderna per year

65.49$ 497.49$
Min Max

Summary analysis Moderna

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Moderna

Revenue and net income Moderna

All parameters
Stock news Moderna All news

Moderna Inc. stock falls Wednesday, underperforms market

Moderna Inc. stock falls Wednesday, underperforms market

Moderna Inc. stock underperforms Tuesday when compared to competitors

Moderna Inc. stock underperforms Tuesday when compared to competitors

Moderna says it will start developing a monkeypox vaccine

FDA panel to review Pfizer and Moderna vaccines for children aged six month to 4 years on June 15

Billionaire Moderna CEO Stéphane Bancel Pledges Stock Options Worth $355 Million To Undisclosed Charitable Causes

Coronavirus tally: FDA advisory panel to meet June 15 to discuss Pfizer, BioNTech and Moderna vaccines for children aged 6 months to 4 years

Moderna Inc. stock rises Monday, still underperforms market

Moderna Inc. stock falls Friday, underperforms market

Moderna Inc. stock falls Friday, underperforms market

Pfizer and Moderna created life-saving vaccines. So why are their stocks crumbling?

Moderna Inc. stock outperforms competitors on strong trading day

Moderna Inc. stock outperforms competitors on strong trading day

Moderna Ready to Ship Covid-19 Shots for Kids as Early as June

Moderna Inc. stock falls Wednesday, still outperforms market

Moderna Inc. stock falls Wednesday, still outperforms market

Moderna Inc. stock outperforms market on strong trading day

Moderna Inc. stock outperforms market on strong trading day

Moderna Inc. stock outperforms market despite losses on the day

About company Moderna

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, Metagenomi, Inc., and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Address:
200 Technology Square, Cambridge, MA, United States, 02139
Company name: Moderna
Issuer ticker: MRNA
ISIN: US60770K1079
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-12-07
Sector: Healthcare
Industry: Biotechnology
Site: https://www.modernatx.com

On which stock exchange are Moderna (MRNA) stocks traded?

Moderna (MRNA) stocks are traded on NASDAQ.

What is the ticker of Moderna stocks (MRNA)?

The stock ticker of Moderna’s stocks or in other words, the code is MRNA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Moderna (MRNA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Moderna (MRNA) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Moderna (MRNA) stocks traded?

Moderna (MRNA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Moderna (MRNA) stocks today?

The current price of Moderna stocks on 26.05.2022 is 132.06 dollars. per share.

What is the dynamics of Moderna (MRNA) stocks from the beginning of the year?

Moderna (MRNA) quotes have increased by 0% from the beginning of the year up to 132.06 dollars. per 1 stocks.

How much did Moderna (MRNA) stocks increase in мае 2022?

This month Moderna (MRNA) quotes have increased by 0% to 132.06 dollars. per share.

How much are Moderna (MRNA) stocks worth?

Today, on October, 26.05.2022 Moderna’s (MRNA) stocks cost 132.06 dollars..

What is the market capitalization of Moderna (MRNA)?

Capitalization is the market value of Moderna (MRNA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 26.05.2022, the market capitalization of Moderna (MRNA) is estimated at about 56917860000 dollars.